Literature DB >> 33037530

Plasma microRNA levels in childhood IgA vasculitis.

Alper Han Cebi1, Ferhat Demir2, Mevlit Ikbal3, Mukaddes Kalyoncu2.   

Abstract

INTRODUCTION: Immunoglobulin A vasculitis (IgAV) is the most common form of childhood systemic vasculitis. It is mostly self-limiting and characterized by skin, joint, gastrointestinal tract, and kidney involvement. Microribonucleic acids (miRNAs) are 18-25 base-long non-coding RNA group acting on gene expression. They have been shown to be effective on the immune system studies to date.
METHOD: In our study, 24 IgAV children with skin and joint involvement and 24 healthy children were included. Five different miRNAs (miR-33, miR-34, miR-122, miR-204, and miR451) known to be expressed in plasma and related with autoimmunity pathogenesis were evaluated. miRNAs were compared between the active period of the disease, the post-treatment period, and the healthy group using the real-time PCR method.
RESULTS: Expression levels of miRNA-33 and miRNA-34 increased significantly in active period of the patients compare with inactive period and control groups. The expression levels of miRNA-122 and miRNA-204 decreased significantly in active period of the patients compare with other two groups. There was no significant difference in miRNA-451 levels.
CONCLUSIONS: With the experience we gained from our recent studies, we think that miRNA-204 may be a significant biomarker in autoimmune diseases. Our study is the first study between IgAV and miRNAs in children. More studies are needed to reveal this relationship. Key Points • This is the first paper to show the relationship between miRNAs and childhood IgAV. • It will provide a new perspective to evaluate the pathogenesis of the disease.

Entities:  

Keywords:  Autoimmunity; Immunoglobulin A vasculitis; MicroRNAs; miRNA-204

Mesh:

Substances:

Year:  2020        PMID: 33037530     DOI: 10.1007/s10067-020-05441-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  4 in total

1.  MicroRNA‑33 regulates the NLRP3 inflammasome signaling pathway in macrophages.

Authors:  Qingyun Xie; Meng Wei; Bo Zhang; Xia Kang; Da Liu; Wei Zheng; Xianming Pan; Yi Quan; Dongfa Liao; Jun Shen
Journal:  Mol Med Rep       Date:  2017-12-08       Impact factor: 2.952

2.  Late-onset IgA vasculitis in adult patients exhibits distinct clinical characteristics and outcomes.

Authors:  Seokchan Hong; Soo Min Ahn; Doo-Ho Lim; Byeongzu Ghang; Won Seok Yang; Sang Koo Lee; Yong-Gil Kim; Chang-Keun Lee; Bin Yoo
Journal:  Clin Exp Rheumatol       Date:  2016-01-26       Impact factor: 4.473

3.  Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes.

Authors:  Peter Willeit; Philipp Skroblin; Alexander R Moschen; Xiaoke Yin; Dorothee Kaudewitz; Anna Zampetaki; Temo Barwari; Meredith Whitehead; Cristina M Ramírez; Leigh Goedeke; Noemi Rotllan; Enzo Bonora; Alun D Hughes; Peter Santer; Carlos Fernández-Hernando; Herbert Tilg; Johann Willeit; Stefan Kiechl; Manuel Mayr
Journal:  Diabetes       Date:  2016-11-29       Impact factor: 9.461

Review 4.  Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Human Infectious Diseases.

Authors:  Parmila Verma; Rajan K Pandey; Priyanka Prajapati; Vijay K Prajapati
Journal:  Front Microbiol       Date:  2016-08-15       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.